Company · CIK 0001411685
Vistagen Therapeutics, Inc.
VTGNSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$0.16−$0.01 (−3.65%)
VTGN · Last trade
- Prev close
- $0.17
- Range (30d)
- $0.16 – $0.25
On the record
Recent filings
- 8-KVTGNCurrent report0001628280-26-065559 · 395.6 KBSEC(opens sec.gov)
- 8-KVTGNCurrent report0001628280-26-063510 · 8.6 MBSEC(opens sec.gov)
- 8-KVTGNCurrent report0001628280-26-063316 · 163.5 KBSEC(opens sec.gov)
- 8-KVTGNCurrent report0001628280-26-063046 · 188.9 KBSEC(opens sec.gov)
- 8-KVTGNCurrent report0001628280-26-061445 · 153.0 KBSEC(opens sec.gov)
- SCHEDULE 13G/AVTGNVistagen Therapeutics, Inc.0000947871-26-000804 · 16.6 KBSEC(opens sec.gov)
- SCHEDULE 13G/AVTGNVistagen Therapeutics, Inc.0001193125-26-352371 · 22.7 KBSEC(opens sec.gov)
- 10-QVTGNQuarterly update0001628280-26-057116 · 5.2 MBSEC(opens sec.gov)
- SCHEDULE 13G/AVTGNVistagen Therapeutics, Inc.0001831942-26-000032 · 15.8 KBSEC(opens sec.gov)
- 8-KVTGNCurrent report0001628280-26-056953 · 241.3 KBSEC(opens sec.gov)
Insiders
- Adler Reid G.Chief Legal Officer
- Anderson Cynthia LynnCHIEF FINANCIAL OFFICER
- Angelov Angel SChief Medical Officer
- Bonfiglio Gregory A.Director
- Cato Allen Easley10% Owner
- Commodore Capital LP10% Owner
- Cote Elissa S.Chief Corp Development Officer
- Cunningham Ann MichelleDirector
- Curley JoanneDirector
- DOTSON JERROLD DUANEVP, CFO
Tickers
Addresses
business
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO, CA, 94080
mailing
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO, CA, 94080
Former names
- Excaliber Enterprises, Ltd.2011-06-08
Same industry